We4 Insights

Healthcare is evolving, and so is innovation.

Join our community to explore the latest insights on digital health, clinical research, telemedicine, and regulatory transformation.
Get updates, expert perspectives, and t
hought leadership straight to your inbox.

Stay informed. Stay ahead.

Healthcare evolves fast and innovation doesn’t wait.
Subscribe to receive updates on digital health, clinical research, telemedicine,
and regulatory strategy.

Expert insights, real-world perspectives, and key events from the We4 ecosystem delivered directly to your inbox.
Because better decisions start with better knowledge.

Newsletter Form
  • MDR – Racing Against Time for Your CE Mark

    MDR – Racing Against Time for Your CE Mark

    The extension is here, but it’s not a safety net. Learn how to move fast, stay compliant, and protect your market share. With Regulation (EU) 2023/607, the European Commission has introduced a critical extension to MDR deadlines for legacy devices certified under the previous MDD (Directive 93/42/EEC). It’s a valuable opportunity—but not an excuse to delay.…

  • GCP R3 – Episode 1: What you need to know (Especially if you work in MedTech)

    GCP R3 – Episode 1: What you need to know (Especially if you work in MedTech)

    GCP R3: GCP is evolving, are you? The ICH has released the E6(R3) revision of Good Clinical Practice (GCP), and it marks a turning point. With this update, the rules of clinical evidence have changed, and if you’re working on medical devices, SaMD or digital health, you’re in the game now too. No need to worry, here’s a…

  • MDR 2025: What’s Really Changing and How to Prepare Now

    MDR 2025: What’s Really Changing and How to Prepare Now

    The MDR deadline extension is not a pause. It’s a strategic opportunity – but only if you act early. Back in early 2024, the European Commission granted more time for companies to align with Regulation (EU) 2017/745 (MDR) – particularly concerning legacy devices. While many manufacturers welcomed the extra breathing room, be careful: more time doesn’t mean fewer…

  • We4 Clinical Research Prepares for the Gender Equality Certification: Our Commitment to an Equitable and Inclusive Work Environment

    We4 Clinical Research Prepares for the Gender Equality Certification: Our Commitment to an Equitable and Inclusive Work Environment

    In recent years, the issue of gender equality has taken on central importance. Companies are actively working to ensure equal opportunities, pay equity, and inclusive environments where every employee can fully realize their potential. At We4 Clinical Research, we firmly believe that valuing diversity is essential for driving innovation, productivity, and sustainable growth. Towards the…

  • How to Streamline Ethics Committees for Faster Clinical Research in Italy

    How to Streamline Ethics Committees for Faster Clinical Research in Italy

    Clinical research is a fundamental pillar for the progress of medicine and the development of new therapies. The role of the Ethics Committees (ECs), independent bodies responsible for evaluating and approving trials, is a crucial element in ensuring ethical and safe clinical trials, ensuring that participants’ rights, safety and well-being are protected. In the past, the fragmentation…

  • AI and Automated Systems in Clinical Research: Support, Limits, and Why the CRA Cannot Be Replaced

    AI and Automated Systems in Clinical Research: Support, Limits, and Why the CRA Cannot Be Replaced

    Artificial Intelligence (AI) and automated systems are transforming the clinical research sector, improving data collection and analysis, optimizing decision-making processes, and reducing study time and costs. However, while these technologies offer valuable support, it is essential to understand that they cannot replace the Clinical Research Associate (CRA) nor human judgment. At We4CR, we use AI…